Insmed INSM
NASDAQ INSM
$126.29 -0.39 (-0.31%)
At close: Sep 4, 2026 · 4:00 PM EDT

Insmed (INSM) Assets (2011 - 2026)

Insmed (INSM) posted Assets of $2.1 billion for Q2 2026, up 1.29% on a QoQ basis from $2.1 billion in Q1 2026, and down 15.21% year-over-year from $2.5 billion in Q2 2025.

Analysis

Insmed (INSM) Assets (2011 - 2026) Analysis & Trends

Insmed has reported Assets for 16 years, with the latest figure at $2.1 billion in Q2 2026.

  • On a quarterly basis, Assets fell 15.21% year-over-year to $2.1 billion in Q2 2026; TTM through Jun 2026 was $2.1 billion, a 15.21% decrease from a year earlier, with the FY2025 full-year figure at $2.3 billion, up 11.82% from the prior year.
  • Assets was $2.1 billion for Q2 2026 at Insmed, up from $2.1 billion in the prior quarter.
  • The five-year high for Assets was $2.5 billion in Q2 2025, with the low at $994.8 million in Q3 2022.
  • Average Assets over 5 years is $1.7 billion, with a median of $1.7 billion recorded in 2022.
  • The largest YoY upside for Assets was 66.57% in 2022 against a maximum downside of 24.16% in 2022.
  • Over 5 years, Assets stood at $1.7 billion in 2022, then decreased by 19.72% to $1.3 billion in 2023, then soared by 52.29% to $2.0 billion in 2024, then grew by 11.82% to $2.3 billion in 2025, then fell by 7.15% to $2.1 billion in 2026.
  • The last three Assets figures came in at $2.1 billion (Q2 2026), $2.1 billion (Q1 2026), and $2.3 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 95.64 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 49.36 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 27.42 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 41.73 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 10.03 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 10.96 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 5.56 Bn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 32.09 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 2.10 Bn
10 BioNTech SE 26.24 Bn 12.58 Bn 10.00 Mn 23.65 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.10 Bn
Mar 31, 2026 2.08 Bn
Dec 31, 2025 2.26 Bn
Sep 30, 2025 2.36 Bn
Jun 30, 2025 2.48 Bn
Mar 31, 2025 1.80 Bn
Dec 31, 2024 2.03 Bn
Sep 30, 2024 2.05 Bn
Jun 30, 2024 1.81 Bn
Mar 31, 2024 1.16 Bn
Dec 31, 2023 1.33 Bn
Sep 30, 2023 1.32 Bn
Jun 30, 2023 1.44 Bn
Mar 31, 2023 1.52 Bn
Dec 31, 2022 1.66 Bn
Sep 30, 2022 994.82 Mn
Jun 30, 2022 1.05 Bn
Mar 31, 2022 1.15 Bn
Dec 31, 2021 1.24 Bn
Sep 30, 2021 1.31 Bn